髓系白血病因子1稳定肿瘤抑制因子C/EBPα以阻止Trib1驱动的急性髓系白血病
本文报道髓系白血病因子1(MLF1)通过抑制Trib1-COP1 E3泛素连接酶的活性来稳定C/EBPα蛋白水平,从而阻止Trib1驱动的急性髓系白血病发生。MLF1在造血干细胞和髓系祖细胞中表达,其缺陷使Trib1诱导的白血病表型更不成熟,Trib1/MLF1高表达比值是白血病发生的关键决定因素,并在人类急性白血病样本中得到验证。
要点
- MLF1直接与COP1相互作用,干扰Trib1-COP1复合物形成,抑制C/EBPα多泛素化降解。
- MLF1过表达抑制Trib1诱导的小鼠骨髓培养生长优势和骨髓移植模型中的AML发生。
- Trib1/MLF1高表达比值是小鼠模型和人类急性白血病中AML发生的关键决定因素。
核心结论
- MLF1是造血早期和白血病发生早期阶段稳定C/EBPα的关键正向调控因子,其通过抑制Trib1-COP1连接酶活性阻止Trib1驱动的AML。
研究设计与样本
- 研究采用小鼠骨髓培养、骨髓移植小鼠模型及人类急性白血病患者样本进行机制与验证研究。
主要发现
- MLF1直接与COP1在细胞核内相互作用,干扰Trib1-COP1复合物形成,阻断其对C/EBPα的多泛素化降解。
- MLF1过表达抑制Trib1诱导的小鼠骨髓培养生长优势及骨髓移植模型中的AML发生。
- MLF1在正常造血中的造血干细胞和髓系祖细胞(共同髓系祖细胞和粒细胞-巨噬细胞祖细胞)中表达,与C/EBPα分布一致。
- MLF1缺陷使Trib1诱导的AML发展呈现更不成熟的表型。
- Trib1/MLF1高表达比值是小鼠模型AML发生的关键决定因素,并在人类急性白血病患者样本中得到证实。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
C/EBPα is a key transcription factor regulating myeloid differentiation and leukemogenesis. The Trib1-COP1 complex is an E3 ubiquitin ligase that targets C/EBPα for degradation, and its overexpression specifically induces acute myeloid leukemia (AML). Here we show that myeloid leukemia factor 1 (MLF1) stabilizes C/EBPα protein levels by inhibiting the ligase activity of the Trib1-COP1 complex. MLF1 directly interacts with COP1 in the nucleus and interferes with the formation of the Trib1-COP1 complex, thereby blocking its ability to polyubiquitinate C/EBPα for degradation. MLF1 overexpression suppressed the Trib1-induced growth advantage in a murine bone marrow (BM) culture and Trib1-induced AML development in BM-transplanted mouse models. MLF1 was expressed in hematopoietic stem cells and myeloid progenitors (common myeloid progenitors and granulocyte-macrophage progenitors) in normal hematopoiesis, which is consistent with the distribution of C/EBPα. An MLF1 deficiency conferred a more immature phenotype on Trib1-induced AML development. A higher expression ratio of Trib1 to MLF1 was a key determinant for AML development in mouse models, which was also confirmed in human patient samples with acute leukemia. These results indicate that MLF1 is a positive regulator that is critical for C/EBPα stability in the early phases of hematopoiesis and leukemogenesis.
引用
- Nakamae I, Kato JY, Yokoyama T, et al. Myeloid leukemia factor 1 stabilizes tumor suppressor C/EBPα to prevent Trib1-driven acute myeloid leukemia. Blood Adv. 2017. PMID: 29296815. doi:10.1182/bloodadvances.2017007054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。